Current Edition

A Novel Valuation Model for Medical Intervention Development

All stakeholders involved in the development, licensing and market access of healthcare technologies use a stage-specific valuation match that integrates risks and outcomes to inform their decision-making. Dr Jonathan Dando and Maximilian Lebmeier of Aestimo discuss the work done to potentially identify and address gaps in the development programmes of medical interventions.

[gview file=””]